Evolution of the management of acute myocardial infarction: A 20th century saga

Lancet

Volumn 352, Issue 9142, 1998, Pages 1771-1774

  Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; ISOPRENALINE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; CLINICAL TRIAL; CORONARY CARE UNIT; HEALTH CARE QUALITY; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HISTORY OF MEDICINE; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; REVASCULARIZATION; SHORT SURVEY; ST SEGMENT ELEVATION;

EID: 0032576345     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03212-7     Document Type: Note

References (36)

1. 1 Fye WB. Acute myocardial infarction: a historical summary. In: Gersh BJ, Rahimtoola SH, eds. Acute myocardial infarction. 2nd edn. New York: Chapman and Hall, 1997: 1-5.
2. 2 Krehl L. Die Ekrankungen des Herzmuskels und die Nervosen Herzkrankheiten. Vienna: Alfred Holder, 1901.
3. 3 Obrastzov WP, Strazhesko ND. Zur Kenntnis der Thrombose der Koronararterien des Herzens. Z Klin Med 1910; 71: 116-32.
4. 4 Herrick JB. Certain clinical features of sudden obstruction of the coronary arteries. JAMA 1912; 59: 2015-20.
5. 5 Howell JD. Early perceptions of the electrocardiogram: from arrhythmia to infarction. Bull Hist Med 1984; 58: 83-98.
6. 6 Wearn JT. Thrombosis of the coronary arteries, with infarction of the heart. Am J Med Sci 1923; 165: 250-76.
7. 7 Parkinson J, Bedford E. Cardiac infarction and coronary thrombosis. Lancet 1928; i: 4-11.
8. 8 Levine SA. Coronary thrombosis: its various clinical features. Baltimore: Williams & Wilkins, 1929.
9. 9 Levine SA, Lown B. Armchair treatment of acute coronary thrombosis. JAMA 1952; 148: 1365-69.
10. 10 Harrison TR, Resnik WH. Etiologic aspects of heart disease (including treatment of the different etiologic types). In: Harrison TR, Beeson PB, Resnik WH, Thorn GW, Wintrobe MM, eds. Principles of internal medicine. 2nd edn. New York: The Balkiston Co, 1950: 1285-89.
11. 11 Kouwenhoven WB, Jude JR, Knickerbocker GG. Closed-chest cardiac massage. JAMA 1960; 173: 94-97.
12. 12 Julian DG. Treatment of cardiac arrest in acute myocardial ischemia and infarction. Lancet 1961; ii: 840-44.
13. 13 Day H. An intensive coronary care area. Dis Chest 1963; 44: 423-27.
14. 14 Swan HJC, Ganz W, Forrester J, et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283: 447-51.
15. 15 Pantridge JF, Geddes JS. A mobile coronary care unit in the management of myocardial infarction. Lancet 1967; i: 271-73.
16. 16 Maroko PR, Braunwald E. Modification of myocardial infarct size after coronary occlusion. Ann Intern Med 1973; 79: 720-33.
17. 17 International Collaborative Group. Reduction of infarct size with early use of timolol in acute myocardial infarction. N Engl J Med 1984; 310: 9.
18. 18 Burchell HB. pathogenesis of myocardial infarction (culpable clot?). Am J Cardiol 1974; 34: 868-69.
19. 19 Fletcher AP, Shery S, Alkjaersig N, Smyrnotis FE, Jick S. The maintenance of a sustained thrombolytic state in man. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1958; 38: 1111.
20. 20 Verstraete M. Thrombolytic therapy in recent myocardial infarction. In: Meltzer LE, Dunning AJ, eds. Textbook of coronary care. Amsterdam: Excerpta Medica, 1972: 643-59.
21. 21 Chazov EI, Matveeva LS, Mazaev AV, et al. Intracoronary administration of fibrinolysin in acute myocardial infarction. Terapeuticheskii Arkhiv 1976; 48: 8-19.
22. 22 Rentrop KP, Blanke H, Karsch KR, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: 354-63.
23. 23 DeWood MA, Spires J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902.
24. 24 Gruppo Italiano Per lo Studio Della Streptochinase Nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; i: 397.
25. 25 ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; i: 349.
26. 26 TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) Trial. N Engl J Med 1985; 312: 932.
27. 27 The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615.
28. 28 The TIMI IIIB Investigators: effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non Q wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation 1994; 89: 1545-56.
29. 29 Hutchins GM, Bulkley GH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978; 41: 1127.
30. 30 Pfeffer MA, Braunwald E. Ventricular remodeling following myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81: 1161-72.
31. 31 Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 69-77.
32. 32 Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997; 278: 2093-98.
33. 33 Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicentre study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31: 23-30.
34. 34 Hillis LD, Forman S, Braunwald E, and the Thrombolysis in Myocardial Infarction (TIMI) Phase III Co-investigators. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990; 16: 313-15.
35. 35 Topol EJ, Burek K, O'Neill WW, et al. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med 1988; 318: 1083-88.
36. 36 Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404-07.